Study Identifies How Many Missed Doses of Humira or Cimzia Can Cause an IBD Flare-up

Study Identifies How Many Missed Doses of Humira or Cimzia Can Cause an IBD Flare-up
Inflammatory bowel disease patients taking the biologicals Humira or Cimzia (certolizumab) are at significant risk of flare-ups if they delay refilling their prescriptions for more than two days out of two weeks, a study found. The research, titled “Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases,” was published in the American Journal of Gastroenterology. AbbVie's Humira (adalimumab) and UCB's Cimzia (certolizumab) inhibit tumor necrosis fact
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *